Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W: Adult acute myeloid leukaemia. Crit Rev Oncol Hematol. 2004, 50: 197-222. 10.1016/j.critrevonc.2003.11.002.
Article
PubMed
Google Scholar
Williams KM, Hakim FT, Gress RE: T cell immune reconstitution following lymphodepletion. Semin Immunol. 2007, 19: 318-30. 10.1016/j.smim.2007.10.004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Auletta JJ, Lazarus HM: Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant. 2005, 35: 835-57. 10.1038/sj.bmt.1704966.
Article
CAS
PubMed
Google Scholar
Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, Tefferi A, Elliot MA, Kaufmann SH, Mesa RA, et al.,: Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia. 2006, 20: 29-34. 10.1038/sj.leu.2404032.
Article
CAS
PubMed
Google Scholar
Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM, Markovic SN: Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia. 2002, 16: 1311-8. 10.1038/sj.leu.2402503.
Article
CAS
PubMed
Google Scholar
Parkman R, Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E, Kurtzberg J, Wagner JE, Kernan NA: Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant. 2006, 12: 919-27. 10.1016/j.bbmt.2006.05.008.
Article
PubMed
Google Scholar
Kim DH, Sohn SK, Won DI, Lee NY, Suh JS, Lee KB: Rapid helper T-cell recovery above 200 × 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant. 2006, 37: 1119-28. 10.1038/sj.bmt.1705381.
Article
CAS
PubMed
Google Scholar
Obeid M, Tesniere A, Panaretakis T, Tufi R, Joza N, van Endert P, Ghiringhelli F, Apetoh L, Chaput N, Flament C, et al.,: Ecto-calreticulin in immunogenic chemotherapy. Immunol Rev. 2007, 220: 22-34. 10.1111/j.1600-065X.2007.00567.x.
Article
CAS
PubMed
Google Scholar
Szczepanski MJ, Szajnik M, Czystowska M, Mandapathil M, Strauss L, Welsh A, Foon KA, Whiteside TL, Boyiadzis M: Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res. 2009, 15: 3325-32. 10.1158/1078-0432.CCR-08-3010.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wang X, Zheng J, Liu J, Yao J, He Y, Li X, Yu J, Yang J, Liu Z, Huang S: Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. Eur J Haematol. 2005, 75: 468-76. 10.1111/j.1600-0609.2005.00537.x.
Article
PubMed
Google Scholar
Wu C, Wang S, Wang F, Chen Q, Peng S, Zhang Y, Qian J, Jin J, Xu H: Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clin Exp Immunol. 2009, 158: 199-204. 10.1111/j.1365-2249.2009.04011.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Vardiman JW, Harris NL, Brunning RD: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002, 100: 2292-302. 10.1182/blood-2002-04-1199.
Article
CAS
PubMed
Google Scholar
Ersvaer E, Hampson P, Hatfield K, Ulvestad E, Wendelbo O, Lord JM, Gjertsen BT, Bruserud O: T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005. Cancer Immunol Immunother. 2007, 56: 913-25. 10.1007/s00262-006-0236-5.
Article
CAS
PubMed
Google Scholar
Bruserud O, Ulvestad E: Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia. J Interferon Cytokine Res. 2000, 20: 947-54. 10.1089/10799900050198381.
Article
CAS
PubMed
Google Scholar
Bruserud O, Ulvestad E, Berentsen S, Bergheim J, Nesthus I: T-lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T-cell proliferation. Scand J Immunol. 1998, 47: 54-62. 10.1046/j.1365-3083.1998.00254.x.
Article
CAS
PubMed
Google Scholar
Bruserud O, Ulvestad E: Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. Cell Immunol. 2000, 206: 36-50. 10.1006/cimm.2000.1725.
Article
CAS
PubMed
Google Scholar
Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud O, Gjertsen BT, Nolan GP: Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell. 2004, 118: 217-28. 10.1016/j.cell.2004.06.028.
Article
CAS
PubMed
Google Scholar
Wendelbo O, Bruserud O: Functional evaluation of proliferative T cell responses in patients with severe T lymphopenia: characterization of optimal culture conditions and standardized activation signals for a simple whole blood assay. J Hematother Stem Cell Res. 2003, 12: 525-35. 10.1089/152581603322448231.
Article
CAS
PubMed
Google Scholar
Bruserud O, Ryningen A, Wergeland L, Glenjen NI, Gjertsen BT: Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts. Haematologica. 2004, 89: 391-402.
CAS
PubMed
Google Scholar
Ersvaer E, Hampson P, Wendelbo O, Lord JM, Gjertsen BT, Bruserud O: Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex. Hematology. 2007, 12: 199-207. 10.1080/10245330701255163.
Article
CAS
PubMed
Google Scholar
Ersvaer E, Olsnes AM, Bruserud O: The Immunological Dilemma: Cellular Innate and Adaptive Immune Response Versus Human Acute Myeloid Leukemia. Open Hematology Reviews. 2007, 1: 1-14.
Article
CAS
Google Scholar
Hampson P, Chahal H, Khanim F, Hayden R, Mulder A, Assi LK, Bunce CM, Lord JM: PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood. 2005, 106: 1362-8. 10.1182/blood-2004-10-4117.
Article
CAS
PubMed
Google Scholar
Schwarzenberger P, Kolls JK: Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J Cell Biochem Suppl. 2002, 38: 88-95. 10.1002/jcb.10054.
Article
PubMed
Google Scholar
Tonks A, Pearn L, Musson M, Gilkes A, Mills KI, Burnett AK, Darley RL: Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia. 2007, 21: 2495-505. 10.1038/sj.leu.2404961.
Article
CAS
PubMed
Google Scholar
Ersvaer E, Skavland J, Ulvestad E, Gjertsen BT, Bruserud O: Effects of interferon gamma on native human acute myelogenous leukaemia cells. Cancer Immunol Immunother. 2006
Google Scholar
Stone RM, Mayer RJ: Treatment of the newly diagnosed adult with de novo acute myeloid leukemia. Hematol Oncol Clin North Am. 1993, 7: 47-64.
CAS
PubMed
Google Scholar
Beran M, Andersson B, Kantarjian H, Keating M, Rios A, McCredie KB, Freireich EJ, Gutterman J: Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon. Leukemia. 1987, 1: 52-7.
CAS
PubMed
Google Scholar
Kim H, Sohn HJ, Kim S, Lee JS, Kim WK, Suh C: Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplant. 2006, 37: 1037-42. 10.1038/sj.bmt.1705373.
Article
CAS
PubMed
Google Scholar
Chen Z, JJ O'Shea: Th17 cells: a new fate for differentiating helper T cells. Immunol Res. 2008, 41: 87-102. 10.1007/s12026-007-8014-9.
Article
CAS
PubMed
Google Scholar
Steinman L: A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007, 13: 139-45. 10.1038/nm1551.
Article
CAS
PubMed
Google Scholar
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006, 441: 235-8. 10.1038/nature04753.
Article
CAS
PubMed
Google Scholar
Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT: Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006, 441: 231-4. 10.1038/nature04754.
Article
CAS
PubMed
Google Scholar
Awasthi A, Murugaiyan G, Kuchroo VK: Interplay between effector th17 and regulatory T cells. J Clin Immunol. 2008, 28: 660-70. 10.1007/s10875-008-9239-7.
Article
CAS
PubMed
Google Scholar
Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W: Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007, 178: 6730-3.
Article
CAS
PubMed
Google Scholar
Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, Berrehar F, Seikour A, Charachon A, Karoui M, Leroy K, et al.,: High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut. 2008, 57: 772-9. 10.1136/gut.2007.123794.
Article
CAS
PubMed
Google Scholar
Piccirillo CA, Shevach EM: Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol. 2001, 167: 1137-40.
Article
CAS
PubMed
Google Scholar
Sakaguchi S, Takahashi T, Yamazaki S, Kuniyasu Y, Itoh M, Sakaguchi N, Shimizu J: Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity. Microbes Infect. 2001, 3: 911-8. 10.1016/S1286-4579(01)01452-6.
Article
CAS
PubMed
Google Scholar
Shimizu J, Yamazaki S, Sakaguchi S: Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol. 1999, 163: 5211-8.
CAS
PubMed
Google Scholar
Litzinger MT, Fernando R, Curiel TJ, Grosenbach DW, Schlom J, Palena C: IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood. 2007, 110: 3192-201. 10.1182/blood-2007-06-094615.
Article
PubMed Central
CAS
PubMed
Google Scholar
Dannull J, Nair S, Su Z, Boczkowski D, DeBeck C, Yang B, Gilboa E, Vieweg J: Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand. Blood. 2005, 105: 3206-13. 10.1182/blood-2004-10-3944.
Article
CAS
PubMed
Google Scholar
Bruserud O, Ersvaer E, Olsnes A, Gjertsen BT: Anticancer Immunotherapy in Combination with Proapoptotic Therapy. Curr Cancer Drug Targets. 2008, 8: 666-675. 10.2174/156800908786733496.
Article
CAS
PubMed
Google Scholar
Hewagama A, Patel D, Yarlagadda S, Strickland FM, Richardson BC: Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun. 2009, 10: 509-16. 10.1038/gene.2009.12.
Article
PubMed Central
CAS
PubMed
Google Scholar